177 related articles for article (PubMed ID: 8475131)
1. Exposure of platelet fibrinogen receptors by zinc ions: role of protein kinase C.
Trybulec M; Kowalska MA; McLane MA; Silver L; Lu W; Niewiarowski S
Proc Soc Exp Biol Med; 1993 May; 203(1):108-16. PubMed ID: 8475131
[TBL] [Abstract][Full Text] [Related]
2. Zinc ions potentiate adenosine diphosphate-induced platelet aggregation by activation of protein kinase C.
Kowalska MA; Juliano D; Trybulec M; Lu W; Niewiarowski S
J Lab Clin Med; 1994 Jan; 123(1):102-9. PubMed ID: 8288949
[TBL] [Abstract][Full Text] [Related]
3. Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid.
Packham MA; Livne AA; Ruben DH; Rand ML
Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):849-56. PubMed ID: 8384448
[TBL] [Abstract][Full Text] [Related]
4. Affinity labeling of a human platelet membrane protein with 5'-p-fluorosulfonylbenzoyl adenosine. Concomitant inhibition of ADP-induced platelet aggregation and fibrinogen receptor exposure.
Figures WR; Niewiarowski S; Morinelli TA; Colman RF; Colman RW
J Biol Chem; 1981 Aug; 256(15):7789-95. PubMed ID: 6267026
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C activation is not a key step in ADP-mediated exposure of fibrinogen receptors on human platelets.
Pulcinelli FM; Ashby B; Gazzaniga PP; Daniel JL
FEBS Lett; 1995 May; 364(1):87-90. PubMed ID: 7772199
[TBL] [Abstract][Full Text] [Related]
6. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
Huang TF; Liu CZ; Ouyang CH; Teng CM
Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
[TBL] [Abstract][Full Text] [Related]
7. A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom.
Huang TF; Sheu JR; Teng CM
Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):351-7. PubMed ID: 1859363
[TBL] [Abstract][Full Text] [Related]
8. KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction.
Mazoyer E; Lévy-Toledano S; Rendu F; Hermant L; Lu H; Fiat AM; Jollès P; Caen J
Eur J Biochem; 1990 Nov; 194(1):43-9. PubMed ID: 2174781
[TBL] [Abstract][Full Text] [Related]
9. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
Puri RN; Zhou FX; Bradford H; Hu CJ; Colman RF; Colman RW
Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293
[TBL] [Abstract][Full Text] [Related]
10. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex.
Huang TF; Holt JC; Lukasiewicz H; Niewiarowski S
J Biol Chem; 1987 Nov; 262(33):16157-63. PubMed ID: 3680247
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ADP-induced platelet responses by covalent modification of aggregin, a putative ADP receptor, by 8-(4-bromo-2,3-dioxobutylthio)ADP.
Puri RN; Kumar A; Chen H; Colman RF; Colman RW
J Biol Chem; 1995 Oct; 270(41):24482-8. PubMed ID: 7592664
[TBL] [Abstract][Full Text] [Related]
12. Weak inhibition of protein kinase C coupled with various non-specific effects make sphingosine an unsuitable tool in platelet signal transduction studies.
Krishnamurthi S; Patel Y; Kakkar VV
Biochim Biophys Acta; 1989 Feb; 1010(2):258-64. PubMed ID: 2492201
[TBL] [Abstract][Full Text] [Related]
13. Exposure of platelet fibrinogen-binding sites by collagen, arachidonic acid, and ADP: inhibition by a monoclonal antibody to the glycoprotein IIb-IIIa complex.
Di Minno G; Thiagarajan P; Perussia B; Martinez J; Shapiro S; Trinchieri G; Murphy S
Blood; 1983 Jan; 61(1):140-8. PubMed ID: 6216929
[TBL] [Abstract][Full Text] [Related]
14. Zinc-induced platelet aggregation is mediated by the fibrinogen receptor and is not accompanied by release or by thromboxane synthesis.
Heyns Adu P; Eldor A; Yarom R; Marx G
Blood; 1985 Jul; 66(1):213-9. PubMed ID: 2988668
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of extra- and intracellular calcium chelation on human platelet function and glycoprotein IIb-IIIa complex stability.
Lanza F; Stierlé A; Gachet C; Cazenave JP
Nouv Rev Fr Hematol (1978); 1992; 34(1):123-31. PubMed ID: 1523093
[TBL] [Abstract][Full Text] [Related]
16. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
Puri RN; Colman RF; Colman RW
Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition.
Horstrup K; Jablonka B; Hönig-Liedl P; Just M; Kochsiek K; Walter U
Eur J Biochem; 1994 Oct; 225(1):21-7. PubMed ID: 7925440
[TBL] [Abstract][Full Text] [Related]
18. Platelet aggregation: its relation with ADP-induced fibrinogen binding to platelets and ADP-related membrane enzyme activities.
Legrand C; Dubernard V; Caen J
Eur J Biochem; 1984 Aug; 142(3):465-71. PubMed ID: 6088225
[TBL] [Abstract][Full Text] [Related]
19. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
[TBL] [Abstract][Full Text] [Related]
20. Effect of epinephrine on fibrinogen receptor exposure by aspirin-treated platelets and platelets from concentrates in response to ADP and thrombin.
Peerschke EI
Am J Hematol; 1984 May; 16(4):335-45. PubMed ID: 6326566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
